Accessibility Menu
Hutchmed (China) logo

Hutchmed (China)

(LSE) HCM

Current Price£1.60
Market Cap£1.40B
Since IPO (2006)+539%
5 Year-65%
1 Year-28%
1 Month-9%

Hutchmed (China) Financials at a Glance

Market Cap

£1.40B

Revenue (TTM)

$602.20M

Net Income (TTM)

$466.88M

EPS (TTM)

£0.40

P/E Ratio

3.96

Dividend

£0.00

Beta (Volatility)

-0.28 (Low)

Price

£1.60

Volume

8,799

Open

£1.60

Previous Close

£1.60

Daily Range

£1.53 - £1.60

52-Week Range

£1.50 - £2.92

Estimated Earnings Date

Aug 3, 2026

HCM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hutchmed (China)

Industry

Pharmaceuticals

Employees

1,796

CEO

Chig Fung Cheng

Headquarters

Hong Kong, HK

HCM Financials

Key Financial Metrics (TTM)

Gross Margin

11.64%

Operating Margin

-7.14%

Net Income Margin

83.30%

Return on Equity

37.04%

Return on Capital

-4.09%

Return on Assets

26.06%

Earnings Yield

25.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£1.40B

Shares Outstanding

872.34M

Volume

8.80K

Avg. Volume

38.93K

Financials (TTM)

Gross Profit

$53.76M

Operating Income

-$19.70M

EBITDA

-$7.49M

Operating Cash Flow

-$32.57M

Capital Expenditure

-$17.09M

Free Cash Flow

-$49.66M

Cash & ST Invst.

$1.37B

Total Debt

$97.89M

Hutchmed (China) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$138.84M

-9.2%

Gross Profit

$55.05M

-12.3%

Gross Margin

39.65%

N/A

Market Cap

£1.40B

N/A

Market Cap/Employee

£770.70K

N/A

Employees

1,811

N/A

Net Income

$227.48M

+1663.3%

EBITDA

$1.30M

+112.2%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$1.37B

+63.0%

Total Debt

$97.89M

+9.0%

Accounts Receivable

$147.63M

-5.1%

Inventory

$41.13M

-18.4%

Long Term Debt

$70.04M

+10.3%

Short Term Debt

$27.85M

+5.9%

Return on Assets

26.06%

N/A

Return on Invested Capital

-2.72%

N/A

Free Cash Flow

-$41.08M

-64.5%

Operating Cash Flow

-$36.45M

-83.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNS.LGenus plc
£21.58+1.22%
ONT.LOxford Nanopore Technologies plc
£1.24+2.31%
AGY.LAllergy Therapeutics plc
£0.07+0.00%
ANCR.LAnimalcare Group plc
£3.32+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
SPCXSpace Exploration Technologies
$153.23+0.00%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%

Questions About HCM

What is the current price of Hutchmed (China)?

Hutchmed (China) is trading at £1.60 per share.

What is the 52-week range for Hutchmed (China)?

Over the past 52 weeks, Hutchmed (China) has traded between £1.50 and £2.92.

How much debt does Hutchmed (China) have?

As of the most recent reporting period, Hutchmed (China) reported total debt of $72.78M.

How much cash does Hutchmed (China) have on hand?

Hutchmed (China) reported $53.03M in cash and cash equivalents in its most recent financial results.

What is Hutchmed (China)’s dividend yield?

Hutchmed (China) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.